These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9860943)

  • 1. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
    Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
    Wang J; Lou P; Henkin J
    J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
    Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
    Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
    Zhou G; Tsai CW; Liu JO
    J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
    Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE
    Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4.
    Endo H; Takenaga K; Kanno T; Satoh H; Mori S
    J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
    Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
    Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase.
    Lowther WT; McMillen DA; Orville AM; Matthews BW
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12153-7. PubMed ID: 9770455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
    Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK
    ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of human methionine aminopeptidase-2 complexed with fumagillin.
    Liu S; Widom J; Kemp CW; Crews CM; Clardy J
    Science; 1998 Nov; 282(5392):1324-7. PubMed ID: 9812898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
    Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
    Lu J; Chong CR; Hu X; Liu JO
    J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
    Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A
    Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiparasitic activities of novel, orally available fumagillin analogs.
    Arico-Muendel C; Centrella PA; Contonio BD; Morgan BA; O'Donovan G; Paradise CL; Skinner SR; Sluboski B; Svendsen JL; White KF; Debnath A; Gut J; Wilson N; McKerrow JH; DeRisi JL; Rosenthal PJ; Chiang PK
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5128-31. PubMed ID: 19648008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression.
    Turk BE; Su Z; Liu JO
    Bioorg Med Chem; 1998 Aug; 6(8):1163-9. PubMed ID: 9784858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
    Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
    J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state.
    Frottin F; Bienvenut WV; Bignon J; Jacquet E; Vaca Jacome AS; Van Dorsselaer A; Cianferani S; Carapito C; Meinnel T; Giglione C
    Oncotarget; 2016 Sep; 7(39):63306-63323. PubMed ID: 27542228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
    Klein CD; Folkers G
    Oncol Res; 2003; 13(12):513-20. PubMed ID: 12899241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine aminopeptidase 2 is required for HSC initiation and proliferation.
    Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY
    Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.